(Q41646376)

6 October 2017

title

Absence of leukaemic CD34(+) cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered (English)

1 reference

6 October 2017

1 reference

Wendelien Zeijlemaker

1

1 reference

6 October 2017

Angèle Kelder

2

1 reference

6 October 2017

Rolf Wouters

3

1 reference

6 October 2017

Peter J M Valk

4

1 reference

6 October 2017

Birgit I Witte

5

1 reference

6 October 2017

Jacqueline Cloos

6

1 reference

6 October 2017

Gert J Ossenkoppele

7

1 reference

6 October 2017

Gerrit J Schuurhuis

8

1 reference

6 October 2017

language of work or name

English

0 references

publication date

24 June 2015

1 reference

British Journal of Haematology

6 October 2017

published in

1 reference

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias

6 October 2017

cites work

1 reference

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.

21 January 2018

1 reference

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemia

21 January 2018

1 reference

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

21 January 2018

1 reference

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

21 January 2018

1 reference

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

21 January 2018

1 reference

Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms

21 January 2018

1 reference

Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.

21 January 2018

1 reference

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

21 January 2018

1 reference

Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells

21 January 2018

1 reference

CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.

21 January 2018

1 reference

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction

21 January 2018

1 reference

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study

21 January 2018

1 reference

Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia

21 January 2018

1 reference

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia

21 January 2018

1 reference

21 January 2018

1 reference

High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.

21 January 2018

1 reference

CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13572

0 references

1 reference